Pegoraro, S. et al. (2017) Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria. Nature Communications, 8, 15273. (doi: 10.1038/ncomms15273) (PMID:28383016) (PMCID:PMC5384206)
|
Text
203728.pdf - Published Version Available under License Creative Commons Attribution. 485kB |
Abstract
No abstract available.
Item Type: | Articles (Erratum) |
---|---|
Additional Information: | Original article: http://eprints.gla.ac.uk/147978/ |
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Otto, Professor Thomas |
Authors: | Pegoraro, S., Duffey, M., Otto, T. D., Wang, Y., Rösemann, R., Baumgartner, R., Fehler, S. K., Lucantoni, L., Avery, V. M., Moreno-Sabater, A., Mazier, D., Vial, H. J., Strobl, S., Sanchez, C. P., and Lanzer, M. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
Journal Name: | Nature Communications |
Publisher: | Nature Research |
ISSN: | 2041-1723 |
ISSN (Online): | 2041-1723 |
Copyright Holders: | Copyright © 2017 The Authors |
First Published: | First published in Nature Communications 8(1):15273 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record